Qube Research & Technologies LTD Sanofi Transaction History

Qube Research & Technologies LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$43.13 - $54.79 $559,266 - $710,461	-12,967 Reduced 17.63%	60,581 $3.01 Million
Q3 2023 Nov 13, 2023	BUY	$50.95 - $55.2 $3.75 Million - $4.06 Million	73,548 New	73,548 $3.95 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $13.4 Million - $36.2 Million	360,118 Added 581.78%	422,017 $16 Million
Q2 2022 Aug 15, 2022	SELL	$48.99 - $57.46 $3.48 Million - $4.08 Million	-71,001 Reduced 53.42%	61,899 $3.1 Million
Q1 2022 May 09, 2022	SELL	$48.48 - $53.65 $475,540 - $526,252	-9,809 Reduced 6.87%	132,900 $6.82 Million
Q4 2021 Feb 01, 2022	BUY	$47.07 - $52.35 $5.38 Million - $5.99 Million	114,399 Added 404.09%	142,709 $7.15 Million
Q3 2021 Nov 12, 2021	SELL	$47.89 - $53.12 $199,749 - $221,563	-4,171 Reduced 12.84%	28,310 $1.37 Million
Q2 2021 Aug 13, 2021	BUY	$49.36 - $54.25 $1.6 Million - $1.76 Million	32,481 New	32,481 $1.71 Million
Q1 2021 May 14, 2021	SELL	$45.46 - $50.51 $456,372 - $507,069	-10,039 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$45.3 - $51.62 $1.71 Million - $1.95 Million	-37,744 Reduced 78.99%	10,039 $488,000
Q3 2020 Nov 12, 2020	BUY	$49.47 - $53.77 $1.92 Million - $2.09 Million	38,872 Added 436.22%	47,783 $2.4 Million
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $24,201 - $29,610	564 Added 6.76%	8,911 $455,000
Q1 2020 May 15, 2020	BUY	$38.02 - $51.66 $317,352 - $431,206	8,347 New	8,347 $365,000
Q2 2018 Aug 14, 2018	SELL	$37.63 - $41.22 $269,807 - $295,547	-7,170 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$38.98 - $45.76 $279,486 - $328,099	7,170 New	7,170 $287,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.